1082
E. Cleator et al. / Tetrahedron Letters 51 (2010) 1079–1082
K. G.; Waring, M. J. PCT Int. Appl., WO2006125972, 2006; Chem. Abstr. 2006,
Table 3
146, 27865.
Palladium-catalyzed cross-couplings
4. As an example, in Ref. 3a, the ring closure of an alcohol onto an aryl fluoride
using NaH in DMF has been used. See also: (a) White, E. H.; Lim, H. M. J. Org.
Chem. 1987, 52, 2162–2166; (b) Bliss, A. D.; Cline, W. K.; Hamilton, C. E.;
Sweeting, O. J. Org. Chem. 1963, 28, 3537–3541; (c) Penso, M.; Albanese, D.;
Landini, D.; Lupi, V.; Tagliabue, A. J. Org. Chem. 2008, 73, 6686–6690.
5. Cleator, E.; Sheen, F. J.; Bio, M. M.; Brands, K. M. J.; Davies, A. J.; Dolling, U.-H.
Tetrahedron Lett. 2006, 47, 4245–4248.
Entry
Product
Starting
material
Yield (%)
O
O
Ph
S
F
N
6. The ring-opening of epoxides with sulfonamides has been outlined in the
literature, see: Baker, B. R.; Kadish, A. F.; Querry, M. V. J. Org. Chem. 1950, 2,
400–401; The conditions outlined here were discovered in our previous work,
see Ref. 5, which were adapted from Albanese et al., see: Albanese, D.; Landini,
D.; Penso, M.; Petricci, S. Tetrahedron 1999, 20, 6387–6394.
1
11a
11b
1b
1b
88
O
OBn
N
N
O
S
7. General procedure for the multicomponent cyclization reaction: sulfonyl chloride
O
Ph
(1.0 mmol) was added to
a solution of K2CO3 (2.5 mmol) and tetra-n-
F
N
butylammonium bromide (0.1 mmol) in 1,4-dioxane (10 mL/g). Benzylamine
(1.0 mmol) and epoxide (1.0 mmol) were added and the reaction mixture was
heated to reflux and stirred for 72 h. The reaction mixture was allowed to cool
to room temperature and was diluted with water (10 mL/g). The mixture was
extracted with EtOAc (3 Â 15 mL/g) and the combined organic extracts were
dried over MgSO4, filtered and concentrated in vacuo. The crude products were
purified by silica gel flash chromatography. Characterization of
benzoxathiazepine 1d. Colourless oil. 1H NMR (400 MHz, CDCl3) dH 7.75 (1H,
d, J = 8.4, Ar–H), 7.30–7.13 (12H, m, Ar–H), 4.49 (2H, s, OCH2Ph), 4.45 (1H, d,
J = 14.4, NCHACHBPh), 4.26–4.20 (1H, m, OCH), 3.84 (1H, d, J = 14.4,
NCHACHBPh), 3.76 (1H, dd, J = 15.2 and 10.8, CHACHBOBn), 3.66–3.62 (1H, m,
NCHACHBCH), 3.48–3.44 (1H, m, NCHACHBCH), 3.20 (1H, dd, J = 15.2 and 1.6,
CHACHBOBn); 13C NMR (100 MHz, CDCl3) dC 155.8, 139.8, 137.6, 135.2, 133.0,
130.1, 129.0, 128.7, 128.4, 128.1, 127.4, 124.9, 124.0, 77.8, 73.8, 70.1, 51.9,
49.5; HRMS (ESI+) calcd for C23H22ClNNaO4S 466.0856 [M+Na]+, found
466.0859 [M+Na]+.
2
71
O
OBn
F3C
O
S
O
Ph
N
3
4
11c
11d
1d
1h
72
36
O
OBn
Ph
N
N
O
S
O
F
N
8. Determined by chiral HPLC. Conditions, Chiral AD; eluent 20% iso-propyl
alcohol in hexanes containing 0.1% TFA.
O
9. Billingsley, K.; Buchwald, S. L. J. Am. Chem. Soc. 2007, 129, 3358–3366.
10. General procedure 1 for the Suzuki coupling: the aryl halide (1.0 equiv), boronic
acid (1.05 equiv), PdCl2dppf–CH2Cl2 adduct (10 mol %) and potassium
phosphate, dibasic (2.0 equiv) were added to a sealable tube containing a
magnetic stir bar. Dioxane (10 mL/g) was added and the mixture was degassed
by evacuating the system and back-filling with nitrogen for three times. The
tube was sealed, heated to 100 °C and stirred for 19 h. The reaction was
quenched by the addition of water (10 mL/g), the product was extracted with
EtOAc (3 Â 10 mL/g) and the combined organics were concentrated in vacuo to
yield the crude product. The product was purified using silica gel flash
chromatography.
1 and the extension of this methodology towards the synthesis of
benzothiadiazepines are currently underway.
Acknowledgements
11. General procedure 2 for the Suzuki coupling: the benzoxathiazepine (1 equiv)
was dissolved in dioxane (10 mL/g) and the boronic acid (1.05 equiv) and
palladium (diphenylphosphino)dichloride were added (3 mol %). Sodium
carbonate (2 M, 1.2 equiv) was then added and the reaction mixture was
heated to reflux for 90 min. The reaction was quenched by the addition of
water (10 mL/g) and then extracted with EtOAc (3 Â 10 mL/g). The combined
organic layers were dried (MgSO4), filtered and then concentrated in vacuo
We thank Simon Hamilton and Sophie Strickfuss from the MSD
analytical research group at Hoddesdon for mass spectrometry
work and chiral HPLC analysis.
References and notes
to give
a yellow oil which was purified by column chromatography.
Characterization of 11a. Clear oil. 1H NMR (400 MHz, CDCl3) dH 7.84 (2H, m)
7.70–7.62 (4H, m) 7.58–7.46 (4H, m) 7.42–7.23 (4H, m), 4.63 (3H, m) 4.27–4.25
(1H, m) 4.0 (3H, s), 3.92–3.87 (2H, m), 3.78–3.74 (1H, m), 3.58–3.55 (1H, m)
3.28 (1H, d, J = 14 Hz); 13C NMR (60 MHz) dC 138.0, 137.6, 135.1, 132.2, 132.1,
131.9, 130.1, 130.0, 128.8, 128.5 (m), 128.4, 128.2, 127.9, 127.6, 121.4 (d),
116.6, 116.3, 77.2, 73.6, 70.1, 51.6, 49.5, 39.3; HRMS (ESI+) calcd for
C27H27FN3O4S 508.1706 [M+H]+, found: 508.1726 [M+H]+.
1. (a) Eckert, H. Heterocycles 2007, 73, 149–158; (b) Hulme, C.; Gore, V. Curr. Med.
Chem. 2003, 10, 51–80; (c) Weber, L. Curr. Med. Chem. 2002, 9, 2085–2093; (d)
Weber, L.; Illgen, K.; Almstetter, M. Synlett 1999, 366–374.
2. Santora, V. J.; Covel, J. A.; Ibarra, J. B.; Semple, G.; Smith, B.; Smith, J.;
Weinhouse, M. I.; Schultz, J. A. PCT Int. Appl., WO 2008005338, 2008; Chem.
Abstr. 2008, 148, 144502.
3. (a) Campbell, L.; Pike, K. G.; Suleman, A.; Waring, M. J. PCT Int. Appl., WO
2008050101, 2008; Chem. Abstr. 2008, 148, 495984.; (b) McKerrecher, D.; Pike,